by Scott Larrivee | Sep 27, 2024 | Blog
September 2024 – Insights Care recently interviewed Nusano CEO Chris Lowe for its “5 Most Trusted Radiopharmaceutical Companies to Watch” edition. Lowe discussed the urgent need for new medical radioisotope supplies, how Nusano will be part of the...
by Scott Larrivee | Jul 10, 2024 | News
VALENCIA, Calif. and BOCA RATON, Fla. – July 10, 2024 – Nusano Inc. (Nusano), a physics company transforming the production of medical radioisotopes, and PharmaLogic Holdings Corp. (PharmaLogic), a leading radiopharmaceutical contract development and manufacturing...
by Scott Larrivee | Apr 10, 2024 | News
VALENCIA, Calif. – April 10, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced it will attend and present at Jefferies Radiopharma Innovation Summit in New York City on Thursday, April 11, 2024. In his presentation,...
by Scott Larrivee | Feb 26, 2024 | News
VALENCIA, Calif. – February 26, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced it will participate in a presentation and panel at the B. Riley Securities Radiopharma Investor Conference in New York City on...
by Scott Larrivee | Sep 15, 2023 | News
Executive with three decades of successful multinational operations and commercial experience to lead launch of proprietary radioisotope production platform VALENCIA, Calif. – Sept. 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting...
